glp-1 medications in the workplace Navigate Comparing GLP-1 Medications for Diabetes

References 1.Cosentino K., Ros U., Garca-Sez A.J

Elderly Insomnia Trial (46 participants) Participants took 500 mg of magnesium daily for 8 weeks

D.DucheminJ.NeyrinckA

These drugs have been associated with numerous severe complications, including: Gastrointestinal Injuries: Gastroparesis (stomach paralysis) Severe bowel obstruction requiring hospitalization Chronic nausea, vomiting, and dehydration Gastroesophageal reflux disease (GERD) Gallbladder and Liver Problems: Acute gallbladder disease (cholecystitis) Gallstone formation Chronic gallbladder inflammation Liver failure in severe cases Kidney and Pancreatic Complications: Acute kidney injury or failure Pancreatitis requiring hospitalization Increased risk of pancreatic cancer Other Serious Conditions: Thyroid tumors or cancer Severe dehydration and malnutrition Intestinal injuries leading to death in extreme cases How GLP-1 Drugs Cause Stomach Paralysis and Other Injuries The mechanism that makes GLP-1 drugs effective for weight loss slowing gastric emptying can also cause serious harm

Restarting the medication helped restore some protection, but only partially, showing that discontinuation leaves a lasting scar. Healio previously reported that the discontinuation of GLP-1 receptor agonists was tied to weight regain and higher risks for some adverse pregnancy outcomes like gestational diabetes and preterm delivery

These agents potentially have complementary effects in cardiovascular and renal protection (Graphical Abstract)